To halt brain diseases, drugs take aim at protein traffic jams that kill neurons
Elie Dolgin • January 16, 2019
Compound that normalizes flow of proteins in cells will now be tested in a clinical trial for ALS
Continue reading at Science Magazine.
Fresh treatments shift the focus from symptom management to repair.
Smart algorithms take aim at antimicrobial resistance.